Henrik Sengeloev

1.1k total citations
22 papers, 292 citations indexed

About

Henrik Sengeloev is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Henrik Sengeloev has authored 22 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in Henrik Sengeloev's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). Henrik Sengeloev is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Myeloid Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). Henrik Sengeloev collaborates with scholars based in Denmark, France and United Kingdom. Henrik Sengeloev's co-authors include Arnon Nagler, Mohamad Mohty, Jan J. Cornelissen, Didier Blaise, Myriam Labopin, Niels Smedegaard Andersen, Lone Smidstrup Friis, Annalisa Ruggeri, Hanne Vibeke Marquart and Lars P. Ryder and has published in prestigious journals such as Blood, Cancer and Clinical Cancer Research.

In The Last Decade

Henrik Sengeloev

21 papers receiving 289 citations

Peers

Countries citing papers authored by Henrik Sengeloev

Since Specialization

Citations

This map shows the geographic impact of Henrik Sengeloev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Sengeloev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Sengeloev more than expected).

Fields of papers citing papers by Henrik Sengeloev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Sengeloev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Sengeloev. The network helps show where Henrik Sengeloev may publish in the future.

Co-authorship network of co-authors of Henrik Sengeloev

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Sengeloev. A scholar is included among the top collaborators of Henrik Sengeloev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Sengeloev. Henrik Sengeloev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Excellent Outcomes in Patients Receiving Tisagenlecleucel for R/R B-Cell ALL: Results from the European Post-Authorization Safety Study (PASS), on Behalf of the Ctiwp, PDWP and ALWP of the EBMT. 2025 ·Transplantation and Cellular Therapy ·Krzysztof Kałwak, Annalisa Ruggeri, (unknown), (unknown), Isabel Sánchez‐Ortega, Chiara Bonini, Éolia Brissot, Tayfun Güngör, Peter Bader, Friso Calkoen, Henrik Sengeloev, Michael Daskalakis, Stephen Robinson, (unknown), Emma Nicholson, Anne Sîrvent, Jürgen Kuball, Fabio Ciceri, Christian Chabannon, (unknown)	0
2	Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemia 2024 ·HemaSphere ·(unknown), Myriam Labopin, (unknown), (unknown), Igor Wolfgang Blau, Johannes Schetelig, Arnold Ganser, Rose‐Marie Hamladji, Wolfgang Bethge, Nicolaus Kröger, Gèrard Socié, Urpu Salmenniemi, Henrik Sengeloev, Bhagirathbhai Dholaria, Bipin N. Savani, Arnon Nagler, (unknown), Mohamad Mohty	1
3	Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia—Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study 2023 ·Cancer ·Rama Al Hamed, (unknown), Jacques‐Emmanuel Galimard, Henrik Sengeloev, Tobias Gedde‐Dahl, Alexander Kulagin, Uwe Platzbecker, Ibrahim Yakoub‐Agha, Jenny Byrne, Thomas Valerius, Gèrard Socié, Nicolaus Kröger, Didier Blaise, Ali Bazarbachi, Jaime Sanz, Fabio Ciceri, Arnon Nagler, Mohamad Mohty	3
4	Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT 2021 ·Blood Cancer Journal ·Maria Gilleece, Avichai Shimoni, Myriam Labopin, Stephen Robinson, Dietrich W. Beelen, Gèrard Socié, Ali Ünal, Arnold Ganser, Antonı́n Vı́tek, Henrik Sengeloev, Ibrahim Yakoub‐Agha, Eleni Tholouli, Emmanuelle Polge, Mohamad Mohty, Arnon Nagler	18
5	Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT 2021 ·Bone Marrow Transplantation ·Frédéric Baron, (unknown), Myriam Labopin, Jan J. Cornelissen, Arnold Ganser, Édouard Forcade, Henrik Sengeloev, Gèrard Socié, Didier Blaise, Martin Bornhäuser, Thomas Valerius, Hans Christian Reinhardt, Nicolaus Kröger, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty	3
6	Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 2019 ·Biology of Blood and Marrow Transplantation ·Avichai Shimoni, Myriam Labopin, Bipin N. Savani, Michael Byrne, Liisa Volin, Jürgen Finke, Dietger Niederwieser, Gerhard Ehninger, Didier Blaise, Dietrich W. Beelen, Reza Tabrizi, Henrik Sengeloev, Arnold Ganser, Jan J. Cornelissen, Mohamad Mohty, Arnon Nagler	12
7	Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT 2019 ·Bone Marrow Transplantation ·(unknown), Eva Domingo‐Doménech, Ariane Boumendil, Fina Climent, Henrik Sengeloev, Björn E. Wahlin, (unknown), Mutlu Arat, Hervé Finel, (unknown), Arnold Ganser, Moshe Yeshurun, Vincenzo Pavone, John A. Snowden, Jürgen Finke, Silvia Montoto, Anna Sureda, Peter Dreger	9
8	Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria 2018 ·Bone Marrow Transplantation ·(unknown), Hiromi Hayashi, Annalisa Ruggeri, Fernanda Volt, Jan J. Cornelissen, Gèrard Socié, Henrik Sengeloev, Mauricette Michallet, Dimitrios Karakasis, Eefke Petersen, J Cahn, Hendrik Veelken, Mélanie Mercier, Pierre‐Simon Rohrlich, Hanadi Rafii, Chantal Kenzey, (unknown), Rafael F. Duarte, Grzegorz Basak, Vanderson Rocha, Éliane Gluckman	1
9	Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT 2018 ·European Journal of Cancer ·Sebastian Giebel, Myriam Labopin, Michael Potter, Xavier Poiré, Henrik Sengeloev, Gèrard Socié, Anne Huynh, Boris V. Afanasyev, Urs Schanz, Olle Ringdén, Peter Kalhs, Dietrich W. Beelen, (unknown), Tamás Masszi, Jonathan Canaani, Mohamad Mohty, Arnon Nagler	29
10	Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen 2018 ·Clinical Cancer Research ·(unknown), Myriam Labopin, Annalisa Ruggeri, Jan J. Cornelissen, Ellen Meijer, Henrik Sengeloev, Dietger Niederwieser, Marco R. de Groot, Harry C. Schouten, Nöel Milpied, Didier Blaise, Bipin N. Savani, Éliane Gluckman, Mohamad Mohty, Arnon Nagler	31
11	C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation 2017 ·Biology of Blood and Marrow Transplantation ·(unknown), Brian Kornblit, Lone S. Friis, (unknown), (unknown), Niels Smedegaard Andersen, Henrik Sengeloev	10
12	Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell–Replete Allogeneic Hematopoietic Stem Cell Transplantation 2016 ·Biology of Blood and Marrow Transplantation ·(unknown), Hanne Vibeke Marquart, Lone Smidstrup Friis, (unknown), (unknown), Lars P. Ryder, Niels Smedegaard Andersen, Henrik Sengeloev	45
13	Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT 2016 ·Blood ·Sebastian Giebel, Myriam Labopin, Michael Potter, Xavier Poiré, Henrik Sengeloev, Gèrard Socié, Anne Huynh, Boris V. Afanasyev, Urs Schanz, Olle Ringdén, Peter Kalhs, Dietrich W. Beelen, (unknown), Tamás Masszi, Mohamad Mohty, (unknown)	1
14	Long-Term Outcome of Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Waldenstrom Macroglobulinemia (WM)-a Retrospective Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 2016 ·Blood ·Charalampia Kyriakou, Ariane Boumendil, Hervé Finel, Norbert Schmitz, Henrik Sengeloev, Stephen Mackinnon, Didier Blaise, Patrice Chevallier, Paul Browne, Charles Craddock, Dietger Niederwieser, Johannes Schetelig, Stig Lenhoff, Nathalie Fegueux, Silvia Montoto, Peter Dreger	1
15	Impact of Different In Vivo T Cell Depletion Strategies on Outcomes Following Hematopoietic Stem Cell Transplantation for Idiopathic Aplastic Anaemia: A Study on Behalf of the EBMT SAA Working Party 2015 ·Blood ·Sujith Samarasinghe, Simona Iacobelli, (unknown), Rose‐Marie Hamladji, Gèrard Socié, Mahmoud Aljurf, Mickey Koh, Henrik Sengeloev, Jean‐Hugues Dalle, Stephen Robinson, Andrea Bacigalupo, Hendrik Veelken, Dietrich W. Beelen, Ghulam J. Mufti, John A. Snowden, Didier Blaise, Judith Marsh, Carlo Dufour, Antonio M. Risitano	5
16	Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood 2013 ·Haematologica ·(unknown), Vanderson Rocha, Peter Dreger, Claudio G. Brunstein, Henrik Sengeloev, Jürgen Finke, Mohamad Mohty, Bernard Rio, Eefke Petersen, François Guilhot, Dietger Niederwieser, Jan J. Cornelissen, Pavel Jindra, Arnon Nagler, Nathalie Fegueux, Hélène Schoemans, Stephen Robinson, Annalisa Ruggeri, Éliane Gluckman, Carmen Canals, Anna Sureda, (unknown)	26
17	Impact of postremission consolidation chemotherapy on outcome after reduced‐intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 2013 ·Cancer ·Moshe Yeshurun, Myriam Labopin, Didier Blaise, Jan J. Cornelissen, Henrik Sengeloev, Lars L. Vindeløv, Juergen Kuball, Patrice Chevallier, Charles Craddock, Gèrard Socié, Karin Bilger, Harry C. Schouten, Nathalie Fegueux, Hakan Göker, Johan Maertens, Donald Bunjes, Renate Arnold, Arnon Nagler, Mohamad Mohty	29
18	Current Outcome Of HLA Identical Sibling Vs Unrelated DONOR Transplants In Severe Aplastic Anemia : An EBMT Analysis 2013 ·Blood ·Andrea Bacigalupo, Gèrard Socié, (unknown), Mahmoud Aljurf, (unknown), Sławomira Kyrcz‐Krzemień, (unknown), Henrik Sengeloev, Ali Ünal, Dietrich W. Beelen, Anna Locasciulli, Carlo Dufour, Jakob Passweg, Rosa Oneto, Judith Marsh	1
19	Extramedullary Leukemia and Myeloid Sarcoma in AML: Results From a Population-Based Registry Study of 2261 Patients 2011 ·Blood ·(unknown), Henrik Sengeloev, Mette Skov Holm, Hans Erik Johnsen, Marianne Tang Severinsen, Eigil Kjeldsen, Olav J. Bergmann, Lone Smidstrup Friis, Morten K. Jensen, Ove Juul Nielsen, Lars Kjeldsen, Jan Maxwell Nørgaard	6
20	Comparison of Low Dose Total Body Irradiation (TBI)-Based Reduced Intensity Conditioning (RIC) Vs. Chemotherapy-Based RIC Prior to Allogeneic Stem Cell Transplantation (allo-SCT) From An HLA Identical Sibling Donor for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1): a Retrospective Analysis of 1200 Patients From the Acute Leukemia Working Party of EBMT. 2009 ·Blood ·Mohamad Mohty, Myriam Labopin, Jeroen J. W. M. Janssen, Ghulam J. Mufti, Jan J. Cornelissen, Nöel Milpied, Henrik Sengeloev, Didier Blaise, Eefke Petersen, Hakan Göker, John G. Gribben, Arnon Nagler, Vanderson Rocha	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact